Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward V Loftus

Showing results (321-330 of 471) with videos related to

Pageof 48
Sort By:
The American Journal of Gastroenterology|May 7, 2004
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapyJean Frédéric Colombel, Edward V Loftus, William J Tremaine, et al.
Inflammatory Bowel Diseases|November 7, 2022
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical ProgramGary R Lichtenstein, Brian Bressler, Carlos Francisconi, et al.
Inflammatory Bowel Diseases|February 22, 2023
The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel DiseaseSiri A Urquhart, Bryce P Comstock, Mauricio F Jin, et al.
Advances in Therapy|March 14, 2023
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's DiseaseEdward V Loftus, Jenny Griffith, Ezequiel Neimark, et al.
The American Journal of Gastroenterology|October 24, 2003
Management of Crohn's disease of the ileoanal pouch with infliximabJean-Frederic Colombel, Elena Ricart, Edward V Loftus, et al.
Crohn'S & Colitis 360|February 3, 2025
Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE RegistryGary R Lichtenstein, Scott D Lee, Brian G Feagan, et al.
The American Journal of Gastroenterology|June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid RegistryGeert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2014
A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitisSiddhant Yadav, Maneesh Dave, Jithinraj Edakkanambeth Varayil, et al.
Abdominal Imaging|June 14, 2008
CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findingsFargol Booya, Salma Akram, Joel G Fletcher, et al.
Melanoma Research|May 2, 2015
Ipilimumab-induced colitis in patients with metastatic melanomaKara M De Felice, Arjun Gupta, Sagar Rakshit, et al.
Pageof 48

Showing results (321-330 of 471) with videos related to

Sort By:
Pageof 48
The American Journal of Gastroenterology|May 7, 2004
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapyJean Frédéric Colombel, Edward V Loftus, William J Tremaine, et al.
Inflammatory Bowel Diseases|November 7, 2022
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical ProgramGary R Lichtenstein, Brian Bressler, Carlos Francisconi, et al.
Inflammatory Bowel Diseases|February 22, 2023
The Incidence of Pouch Neoplasia Following Ileal Pouch-Anal Anastomosis in Patients With Inflammatory Bowel DiseaseSiri A Urquhart, Bryce P Comstock, Mauricio F Jin, et al.
Advances in Therapy|March 14, 2023
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's DiseaseEdward V Loftus, Jenny Griffith, Ezequiel Neimark, et al.
The American Journal of Gastroenterology|October 24, 2003
Management of Crohn's disease of the ileoanal pouch with infliximabJean-Frederic Colombel, Elena Ricart, Edward V Loftus, et al.
Crohn'S & Colitis 360|February 3, 2025
Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE RegistryGary R Lichtenstein, Scott D Lee, Brian G Feagan, et al.
The American Journal of Gastroenterology|June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid RegistryGeert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2014
A population-based study of incidence, risk factors, clinical spectrum, and outcomes of ischemic colitisSiddhant Yadav, Maneesh Dave, Jithinraj Edakkanambeth Varayil, et al.
Abdominal Imaging|June 14, 2008
CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findingsFargol Booya, Salma Akram, Joel G Fletcher, et al.
Melanoma Research|May 2, 2015
Ipilimumab-induced colitis in patients with metastatic melanomaKara M De Felice, Arjun Gupta, Sagar Rakshit, et al.
Pageof 48